Licensing Opportunities

  • Human Sweet and Umami Taste Receptor Variants
    •
       Ref: E-099-2005-0 | Updated: Dec 28, 2016 | NIDCD
  • Tristetraprolin (TTP) Plasmid Vectors for Human and Mouse TTP
    •
       Ref: E-349-2001-0 | Updated: Dec 2, 2016 | NIEHS
  • Immortalized Organ of Corti Cell Line OC-k3
    •
       Ref: E-012-2017-0 | Updated: Nov 10, 2016 | NIDCD
  • Immortalized Stria Vascularis Cell Line SV-k1
    •
       Ref: E-013-2017-0 | Updated: Nov 10, 2016 | NIDCD
  • Non-invasive Pan-Cancer Detection Method
    •
       Ref: E-177-2015-0 | Updated: Nov 8, 2016 | NHGRI
  • Adeno-Associated Virus Gene Therapy for Diabetes and Obesity
    •
       Ref: E-142-2011-0 | Updated: Nov 2, 2016 | NIDCR
  • Enhanced Functionalization of Carbon Nanoparticles for Biomedical Applications
    •
       Ref: E-207-2016-0 | Updated: Oct 13, 2016 | NHLBI
  • Capsid-Free AAV Vectors for Gene Delivery and Their Use for Gene Therapy
    •
       Ref: E-241-2010-0 | Updated: Oct 12, 2016 | NHLBI
  • Optical Microscope Software for Breast Cancer Diagnosis
    •
       Ref: E-286-2012 | Updated: Sep 30, 2016 | NCI
  • Virus-Like Particles That Can Deliver Proteins and RNA
    •
       Ref: E-264-2011 | Updated: Sep 30, 2016 | NCI
  • Bag6 Polyclonal Antibodies That Recognize Human Bag6 Protein
    •
       Ref: E-077-2015-0 | Updated: Sep 8, 2016 | NIDDK
  • Truncated Methanocarba Adenosine Derivatives as A3 Adenosine Receptor Antagonists
    •
       Ref: E-285-2008-0 | Updated: Sep 8, 2016 | NIDDK
  • Capillary Viscometer for Measuring Viscosity of Macromolecular Solutions of Biological Relevance
    •
       Ref: E-231-2012-0 | Updated: Sep 6, 2016 | NIDDK
  • High-Affinity Rabbit Monoclonal Antibodies for Cancer Treatment
    •
       Ref: E-198-2012 | Updated: Sep 6, 2016 | NCI
  • Modulating Chemotherapeutic Cytotoxicity
    •
       Ref: E-296-2011 | Updated: Sep 6, 2016 | NCI
  • Novel Fusion Proteins for HIV Vaccine
    •
       Ref: E-256-2012 | Updated: Sep 6, 2016 | NCI
  • Osmogels: A New Method for Stabilizing Weak Molecular Complex Interactions
    •
       Ref: E-214-2009 | Updated: Sep 6, 2016 | NICHD
  • Phosphodiesterase as a target for cancer therapeutics
    •
       Ref: E-199-2010 | Updated: Sep 6, 2016 | NCI
  • Nitric Oxide-Releasing Polymers for Wound Healing
    •
       Ref: E-157-2012 | Updated: Sep 5, 2016 | NCI
  • 89Zr-Oxine Complex for In Vivo PET Imaging of Labelled Cells and Associated Methods
    •
       Ref: E-080-2014 | Updated: Aug 31, 2016 | NCI
  • Cancer Therapeutic Based on T Cell Receptors Designed to Regiospecifically Release Interleukin-12
    •
       Ref: E-170-2009 | Updated: Aug 31, 2016 | NCI
  • GTF2I Mutations as a Genetic Marker for Prognosis of Thymic Malignancies
    •
       Ref: E-109-2014 | Updated: Aug 31, 2016 | NCI
  • Improved PE-based Targeted Toxins: A Therapeutic with Increased Effectiveness
    •
       Ref: E-269-2009 | Updated: Aug 31, 2016 | NCI
  • Increased Therapeutic Effectiveness of PE-Based Immunotoxins
    •
       Ref: E-263-2011 | Updated: Aug 31, 2016 | NCI
  • Peptide Inhibitors for Viral Infections and as Anti-inflammatory Agents
    •
       Ref: E-167-2010 | Updated: Aug 31, 2016 | NCI
  • Small Molecule MRS5474 with Anticonvulsant Activity for Treatment of Epilepsy
    •
       Ref: E-285-2008-1 | Updated: Aug 31, 2016 | NIDDK
  • Synthetic lipopeptide inhibitors of RAS oncoproteins
    •
       Ref: E-293-2010 | Updated: Aug 31, 2016 | NCI
  • Thalidomide Analogs that Inhibit Inflammation and Angiogenesis
    •
       Ref: E-208-2015 | Updated: Aug 31, 2016 | NIA
  • Use of Anti-CD47 Antibodies for the Treatment of Cancer
    •
       Ref: E-263-2014 | Updated: Aug 31, 2016 | NCI
  • Beta-Amyloid and Tau Fibril Positron Emissions Tomography (PET) Imaging Agents
    •
       Ref: E-156-2006-0 | Updated: Aug 17, 2016 | NIMH
  • Monitoring the Effects of Sleep Deprivation Using Neuronal Avalanches
    •
       Ref: E-345-2013-0 | Updated: Aug 17, 2016 | NIMH
  • Neuronal Decoding Algorithm for Prosthetic Limbs
    •
       Ref: E-038-2001-0 | Updated: Aug 17, 2016 | NIMH
  • Novel Radio-labeled Agents for Imaging Alzheimer's Disease-associated Amyloid
    •
       Ref: E-225-2011-0 | Updated: Aug 17, 2016 | NIMH
  • Therapeutic Peptide Treatment for Dyslipidemic and Vascular Disorders
    •
       Ref: E-138-2008-0 | Updated: Aug 8, 2016 | NHLBI
  • Virus Replicon Particles as Rift Valley Fever Vaccines
    •
       Ref: E-272-2013-0 | Updated: Aug 8, 2016 | CDC
  • Remotely Monitored Mouse Feeding Experimentation Device
    •
       Ref: E-209-2015-0 | Updated: Jul 26, 2016 | NIDDK
  • Field-Adapted Spot Test for Evaluating Materials Treated with Permethrin Insect Repellent
    •
       Ref: E-085-2015-0 | Updated: Jul 19, 2016 | CDC
  • Long Acting Therapeutic Conjugates with Evans Blue
    •
       Ref: E-143-2015-0 | Updated: Jun 27, 2016 | NIBIB
  • Multi-Photon Microscopy System Configured for Multiview Non-Linear Optical Imaging
    •    Ref: E-229-2015-0 | Updated: Jun 27, 2016 | NIBIB
  • Multiplex Assay for Rapid Salmonella Serotyping from Human, Animal, Food and Environmental Sources
    •
       Ref: E-149-2013-0 | Updated: Jun 27, 2016 | CDC
  • Albumin Binding Immunomodulatory Compositions
    •
       Ref: E-149-2016-0 | Updated: Jun 22, 2016 | NIBIB
  • Murine Cell Models for Metastatic Squamous Cell Carcinoma
    •
       Ref: E-213-2016-0 | Updated: Jun 22, 2016 | NIDCD
  • Monoclonal Antibodies for Detection of Stachybotrys chartarum (a Fungus)
    •
       Ref: E-224-2013-0 | Updated: Jun 16, 2016 | CDC
  • Personal Air Sampler for Collecting Airborne Aerosol Particulates for Molecular Analysis by Size
    •
       Ref: E-244-2013-0 | Updated: May 25, 2016 | CDC
  • Anti-Plasmodium Compositions and Methods of Use
    •
       Ref: E-004-2004-2 | Updated: May 24, 2016 | Entremed
  • Generation of Artificial Mutation Controls for Diagnostic Testing
    •
       Ref: E-255-2013-0 | Updated: May 24, 2016 | CDC
  • Mouse Model for Study of Diabetic Nephropathy and Role of Soluble Epoxide Hydrolase
    •
       Ref: E-292-2015-0 | Updated: May 24, 2016 | NIEHS
  • Novel Primate T-cell Lymphotropic Viruses (HTLV, STLV) for Development of Diagnostics, Therapeutics, Research Tools...
    •
       Ref: E-281-2013-0 | Updated: May 24, 2016 | CDC
  • Rabies Vaccine for the Oral Immunization of Domesticated Animals, Wildlife and Feral Animals
    •
       Ref: E-470-2013-0 | Updated: May 24, 2016 | CDC
  • Rapid Anti-Depressant Response Produced by Low Dose Treatment with Anti-Muscarinic Drugs
    •
       Ref: E-175-2004-0 | Updated: May 24, 2016 | NIMH
  • Recombinant MVA Viruses Expressing Clade A/G and Clade B Modified HIV Env, Gag and Pol Genes Useful for HIV Vaccine...
    •
       Ref: E-337-2004-0 | Updated: May 24, 2016 | NIAID
  • Regulation of ATG7 Beclin 1 Program of Autophagic Cell Death by Caspase-8
    •
       Ref: E-318-2004-0 | Updated: May 24, 2016 | NIAID
  • Functional Promoter For CCR5
    •
       Ref: E-222-1997-0 | Updated: May 17, 2016 | NIAID
  • AIB-1, A Steroid Receptor Co-Activator Amplified In Breast And Ovarian Cancer
    •
       Ref: E-018-1997-0 | Updated: May 16, 2016 | NHGRI
  • Local Magnetization Spoiling Using a Gradient Insert for Reducing the Field of View in Magnetic Resonance Imaging...
    •
       Ref: E-123-1997-0 | Updated: May 16, 2016 | NHLBI
  • Thymosin alpha 1 Promotes Tissue Repair, Angiogenesis and Cell Migration
    •
       Ref: E-250-1997-0 | Updated: May 16, 2016 | NIDCR
  • Tumor Tissue Microarrays For Rapid Molecular Profiling
    •
       Ref: E-002-1998-0 | Updated: May 16, 2016 | NHGRI
  • Genes For Niemann-Pick Type C Disease
    •
       Ref: E-122-1997-0 | Updated: May 15, 2016 | NINDS
  • Identification Of The Gene Causing Familial Mediterranean Fever
    •
       Ref: E-257-1997-0 | Updated: May 14, 2016 | NIAMS
  • Development of Dengue Virus Type 3 Vaccine Candidates
    •
       Ref: E-139-2006-0 | Updated: May 9, 2016 | NIAID
  • Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in the 3'-UTR of Dengue Types 1, 2, 3,...
    •
       Ref: E-089-2002-1 | Updated: May 6, 2016 | NIAID
  • Nucleotide and Amino Acid Sequences of the Four Variable Domains of the Major Outer Membrane Proteins of Chlamydia...
    •
       Ref: E-003-1989-0 | Updated: May 6, 2016 | NIAID
  • Therapeutic Approach to Neurodegenerative Disorders Using a TFP5-Peptide
    •
       Ref: E-144-2010-0 | Updated: May 5, 2016 | NINDS
  • Mouse Model and Derived Cells That Hypersecrete Leukemia Inhibitory Factor (LIF)
    •
       Ref: E-175-2011-0 | Updated: May 3, 2016 | NIEHS
  • Mouse Monoclonal Antibodies to Human Tristetraprolin (TTP)
    •
       Ref: E-123-2009-0 | Updated: May 3, 2016 | NIEHS
  • Rapid Molecular Assays for Specific Detection and Quantitation of Loa Loa Microfilaremia
    •
       Ref: E-014-2011-0 | Updated: May 3, 2016 | NIAID
  • A Novel Treatment for Malarial Infections
    •
       Ref: E-202-2008-0 | Updated: Apr 21, 2016 | NIAID
  • Method for Producing Significant Amounts of B19 Virus for Development of Killed or Attenuated Vaccines
    •
       Ref: E-188-2006-0 | Updated: Apr 21, 2016 | NHLBI
  • Non-toxic Compounds that Inhibit the Formation and Spreading of Tumors
    •
       Ref: E-276-2011-0 | Updated: Apr 21, 2016 | NCATS
  • Small-Molecule Inhibitors of Human Galactokinase for the Treatment of Galactosemia and Cancers
    •
       Ref: E-240-2011-0 | Updated: Apr 20, 2016 | NCATS
  • Tagged Form of Mut Enzyme and Its Use in Gene Therapy
    •
       Ref: E-090-2015-0 | Updated: Apr 18, 2016 | NHGRI
  • Rabbit Polyclonal Antibody to Detect a Pro-peptide Fragment of NSAID-activated Gene (NAG-1)/GDF15, a Protein...
    •
       Ref: E-177-2012-0 | Updated: Apr 15, 2016 | NIEHS
  • Polyclonal Antibodies for the Gbeta5-associated Regulator of G Protein Signaling Protein, RGS7
    •
       Ref: E-077-2011-0 | Updated: Apr 11, 2016 | NIDDK
  • Salen-Manganese Compounds for Therapy of Viral Infections
    •
       Ref: E-281-2011-0 | Updated: Apr 11, 2016 | NIAID
  • Transformation-Associated Recombination (TAR) Cloning
    •
       Ref: E-121-1996-0 | Updated: Apr 7, 2016 | NIEHS
  • LRRK2 Inhibitors: Novel Treatment for Intestinal Bowel Disorders
    •
       Ref: E-070-2014-0 | Updated: Mar 22, 2016 | NIAID
  • Software for Fully Automating Myocardial Perfusion Quantification
    •
       Ref: E-097-2016-0 | Updated: Mar 3, 2016 | NHLBI
  • Construct for Tetracycline Inducible Podocyte Specific Gene Expression in Mice
    •
       Ref: E-299-2007-0 | Updated: Feb 23, 2016 | NIDDK
  • UTX LoxP Mouse Model for Oncology Research
    •
       Ref: E-118-2012-0 | Updated: Feb 23, 2016 | NIDDK
  • Antagonist of A3 Adenosine Receptor Fluorescent Probes for the Study of Diseases that Involve A3 Signaling
    •
       Ref: E-073-2012-0 | Updated: Feb 18, 2016 | NIDDK
  • Development of Immune System Tolerance for the Treatment of Autoimmune Disease
    •
       Ref: E-186-2009-0 | Updated: Feb 11, 2016 | NIDCR
  • Use of Antisense Oligodeoxynucleotides for Inhibiting JC Virus
    •
       Ref: E-547-2013-0 | Updated: Feb 11, 2016 | NINDS
  • Mouse Monoclonal Antibodies to MAD1, a Human Spindle Assembly Checkpoint Protein for Maintaining Chromosomal...
    •
       Ref: E-119-2003-0 | Updated: Jan 19, 2016 | NIAID
  • Fluorescent Nanodiamonds as Fiducial Markers for Microscopy
    •
       Ref: E-217-2015-0 | Updated: Jan 14, 2016 | NHLBI
  • Linear Epitopes of Anthrax Toxin Protective Antigen for Development of a Peptide Vaccine
    •
       Ref: E-158-2013-2 | Updated: Jan 14, 2016 | CDC
  • Metallic Nanoparticles for Photothermal Therapy
    •
       Ref: E-158-2015-0 | Updated: Jan 4, 2016 | NIBIB
  • Real Time Medical Image Processing Using Cloud Computing
    •
       Ref: E-074-2014-0 | Updated: Jan 4, 2016 | NHLBI
  • Novel Epstein-Barr Virus Vaccines
    •
       Ref: E-531-2013-0 | Updated: Dec 17, 2015 | NIAID
  • Use of Small Molecules to Treat PARP1-deficient Cancers
    •
       Ref: E-039-2014-0 | Updated: Dec 16, 2015 | NHGRI
  • SIRT1 KO Human Cell Lines Generated by CRISPR/Cas9-mediated DNA Editing
    •
       Ref: E-184-2015-0 | Updated: Nov 30, 2015 | NIEHS
  • Biomarkers for Cancer-Related Fatigue and Their Use in the Management of Such Fatigue (CRF)
    •
       Ref: E-280-2010-0 | Updated: Nov 18, 2015 | NINR
  • Cotranslational Protein Expression System for High-throughput Screening
    •
       Ref: E-300-2012-0 | Updated: Nov 18, 2015 | NCATS
  • Cyclodextrins as Therapeutics for Lysosomal Storage Disorders
    •
       Ref: E-050-2012-0 | Updated: Nov 18, 2015 | NCATS
  • Highly Potent and Selective Deubiquitinating Enzyme Inhibitor
    •
       Ref: E-043-2013-0 | Updated: Nov 18, 2015 | NCATS
  • HIV-Dependent Expression Vector
    •
       Ref: E-276-2003-0 | Updated: Nov 18, 2015 | NIMH
  • Novel Small Molecule Agonists of the Relaxin Receptor as Potential Therapy for Heart Failure and Fibrosis
    •
       Ref: E-072-2012-0 | Updated: Nov 18, 2015 | NCATS
  • Novel Small Molecule Antimalarials for Elimination of Malaria Transmission
    •
       Ref: E-751-2013-0 | Updated: Nov 18, 2015 | NCATS
  • PTH2 and PTH1 Receptor Ligands
    •
       Ref: E-123-1999-0 | Updated: Nov 18, 2015 | NIMH
  • Selective 12-Human Lipoxygenase Inhibitors for the Treatment of Diabetes and Clotting
    •
       Ref: E-134-2010-0 | Updated: Nov 18, 2015 | NCATS
  • Signatures of Genetic Control in Digestive and Liver Disorders
    •
       Ref: E-349-2013-0 | Updated: Nov 18, 2015 | NINR

    Pages


    Displaying 701 - 800 of 1372

    Category Index

    Office of Technology Transfer, Office of Intramural Research, National Institutes of Health

    6011 Executive Blvd, Suite 325, Rockville, MD 20852 | Phone: 301-496-7057